bioRxivSystems BiologyPreprint
Simultaneous classification of neuroactive compounds in zebrafish
Douglas Myers-TurnbulliD, Jack Carson TayloriD, Cole V. M. HelselliD, Matthew N. McCarrolliD, Chris S KiiD, Tia A. TumminoiD, Shreya Ravikumar, Reid Kinser, Leo GendeleviD, Rebekah Alexander, Michael J. KeiseriD, David KokeliD
Abstract
Neuroactive compounds are crucial tools in drug discovery and neuroscience, but it remains difficult to discover neuroactive compounds with new mechanisms of action. To address this need, researchers have developed mid-throughput phenotype-first approaches using zebrafish. This study introduces an open, non-commercial, and extensible hardware/software platform that captures and analyzes drugmodulated phenotypic responses larval zebrafish. We provide full specifications, computer-aided design (CAD) documents, and source code. Accompanying this study, we are also publicly depositing phenotypic data on 3.9 million animals and 34,000 compounds. The data include a high-replicate benchmark set on 14 compounds, a wellcontrolled reference set of 648 known neuroactive compounds, 20 specialized reference sets, a library of 1,520 FDA-approved drugs, 3 screening libraries. This open data resource is curated, structured, tied to extensive metadata, and available under a Creative Commons CC-BY license.
- organism: zebrafish
- assay: imaging
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 11
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Deep phenotypic profiling of neuroactive drugs in larval zebrafish
Leo Gendelev, Jack Carson Taylor, … Michael J. Keiser·Nature CommunicationsPeer-reviewed·Nov 17, 2024
- Multi-behavioral phenotyping in early-life-stage zebrafish for identifying disruptors of non-associative learning
David Leuthold, Nadia K. Herold, … Tamara L. Tal·Environmental Health PerspectivesPeer-reviewed·May 30, 2025
- Pharmacological profiling of brain activity in zebrafish
Richard Kanyo, Ethan Smith, … Harley T. Kurata·bioRxiv·May 29, 2026
- Finding Drug Repurposing Candidates for Neurodegenerative Diseases using Zebrafish Behavioral Profiles
T. D. R. Hernandez, S. V. Gore, … R. Creton·bioRxiv·Sep 12, 2023
- Machine learning enables high-throughput, low-replicate screening for novel anti-seizure targets and compounds using combined movement and calcium fluorescence in larval zebrafish
Christopher Michael McGraw, Annapurna Poduri·European Journal of PharmacologyPeer-reviewed·Aug 5, 2024
- Distinguishing classes of neuroactive drugs based on computational physicochemical properties and experimental phenotypic profiling in planarians
Danielle Ireland, Christina Rabeler, … Eva‐Maria S. Collins·PLoS ONEPeer-reviewed·Jan 30, 2025